| Literature DB >> 17150096 |
Patrick Narbonne1, Richard Roy.
Abstract
Stem cells have recently attracted significant attention largely due to their potential therapeutic properties, but also because of their role in tumorigenesis and their resemblance, in many aspects, to cancerous cells. Understanding how stem cells are regulated, namely with respect to the control of their proliferation and differentiation within a functional organism, is thus primordial to safely profit from their therapeutic benefits. Here, we review recent advances in the understanding of germline stem cell proliferation control by factors that respond to the nutritional status and/or insulin signaling, through studies performed in C. elegans and Drosophila. Together, these data uncover some shared fundamental features that underlie the central control of cellular proliferation within a target stem cell population in an organism. These features may indeed be conserved in higher organisms and may apply to various other stem cell populations.Entities:
Year: 2006 PMID: 17150096 PMCID: PMC1716158 DOI: 10.1186/1747-1028-1-29
Source DB: PubMed Journal: Cell Div ISSN: 1747-1028 Impact factor: 5.130
Figure 1Linking the insulin-like, AMPK and TOR signaling pathways upstream of GSC quiescence. Upon insulin-like receptor activation, PtdInsP3 kinase (PI3K) phosphorylates PtdInsP. This activity is counteracted by PtdInsP3 phosphatase (DAF-18/PTEN). PtdInsPactivates, in a PDK-1/PDK1-dependent manner AKT/Akt, which phosphorylates and thereby prevents the nuclear translocation of the DAF-16/FOXO transcription factor. In Drosophila and mammals, Akt and AMPK act antagonistically to regulate TOR signaling through inhibitory and activating phosphorylation of TSC2, respectively. Arrows indicate activation; bars inhibition. Based on [11, 59, 85, 87, 88].